부산대학교 도서관

Bruinooge, SS; ASCO

JOURNAL OF CLINICAL ONCOLOGY; JUN 15 2003, 21 12, p2397-p2406, 10p.

Goss E; Link MP; Bruinooge SS; Lawrence TS; Tepper JE; Runowicz CD; Schilsky RL

Journal of Clinical Oncology; 8/20/2009, Vol. 27 Issue 24, p4014-4020, 7p

Baer AR; Kelly CA; Bruinooge SS; Runowicz CD; Blayney DW

Journal of Oncology Practice (J ONCOL PRACT), May2010; 6(3): 114-117. (4p)

Berlin J; Bruinooge SS; Tannock IF

Journal of Clinical Oncology (J CLIN ONCOL), 2/1/2007; 25(4): 444-446. (3p)

Forrest SJ; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu.; Gupta H; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ward A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Li YY; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Doan D; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Al-Ibraheemi A; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Alexandrescu S; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Bandopadhayay P; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Shusterman S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Mullen EA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Collins NB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Chi SN; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Wright KD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Kumari P; Dana-Farber Cancer Institute, Boston, MA, USA.; Mazor T; Dana-Farber Cancer Institute, Boston, MA, USA.; Ligon KL; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Shivdasani P; Brigham and Women's Hospital, Boston, MA, USA.; Manam M; Boston Children's Hospital, Boston, MA, USA.; MacConaill LE; Brigham and Women's Hospital, Boston, MA, USA.; Ceca E; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Benich SN; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Schilsky RL; American Society of Clinical Oncology, Alexandria, VA, USA.; Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA, USA.; Guidry Auvil JM; National Cancer Institute, Bethesda, MD, USA.; Cerami E; Dana-Farber Cancer Institute, Boston, MA, USA.; Rollins BJ; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Meyerson ML; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Lindeman NI; Weill Cornell Medical College, New York, NY, USA.; Johnson BE; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Cherniack AD; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Church AJ; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: PubMed not MEDLINE; MEDLINE

Thota R; Intermountain Health, Murray, UT.; Hurley PA; American Society of Clinical Oncology, Alexandria VA.; Miller TM; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY.; Bruinooge SS; American Society of Clinical Oncology, Alexandria VA.; Lipset C; Decentralized Trials and Research Alliance, San Diego, CA.; Harvey RD; Winship Cancer Institute of Emory University, Atlanta, GA.; Black LJ; Sanford Health, Sioux Falls, SD.; Dinsdale A; Montana Cancer Consortium, Billings, MT.; Merrill JK; American Society of Clinical Oncology, Alexandria VA.; Pollastro T; Metastatic Breast Cancer Alliance, New York, NY.; Prindiville SA; NCI Coordinating Center for Clinical Trials, Bethesda, MD.; Rizvi MA; Heimann Cancer Center, Asante Health System, Medford, OR.; Sherwood S; American Society of Clinical Oncology, Alexandria VA.; Nowakowski GS; Mayo Clinic, Rochester, MN.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Forrest SJ; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu.; Gupta H; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ward A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Li YY; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Doan D; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Al-Ibraheemi A; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Alexandrescu S; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Bandopadhayay P; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Shusterman S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Mullen EA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Collins NB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Chi SN; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Wright KD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Kumari P; Dana-Farber Cancer Institute, Boston, MA, USA.; Mazor T; Dana-Farber Cancer Institute, Boston, MA, USA.; Ligon KL; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Shivdasani P; Brigham and Women's Hospital, Boston, MA, USA.; Manam M; Boston Children's Hospital, Boston, MA, USA.; MacConaill LE; Brigham and Women's Hospital, Boston, MA, USA.; Ceca E; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Benich SN; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Schilsky RL; American Society of Clinical Oncology, Alexandria, VA, USA.; Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA, USA.; Guidry Auvil JM; National Cancer Institute, Bethesda, MD, USA.; Cerami E; Dana-Farber Cancer Institute, Boston, MA, USA.; Rollins BJ; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Meyerson ML; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Lindeman NI; Weill Cornell Medical College, New York, NY, USA.; Johnson BE; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Cherniack AD; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Church AJ; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Jazieh AR; Cincinnati Cancer Advisors, Cincinnati, OH, USA.; Bounedjar A; Université Blida 1 Laboratoire de Cancérologie, Faculté de Médecine, Blida, Algeria.; Abdel-Razeq H; King Hussein Cancer Center, Amman, Jordan.; Berna Koksoy E; Ankara University Faculty of Medicine, Medical Oncology Department, Ankara, Turkey.; Ansari J; Tawam Hospital, Al Ain, United Arab Emirates.; Tfayli AH; American University of Beirut, Beirut, Lebanon.; Tashkandi EM; College of Medicine, Umm AlQura University and Oncology Center, King Abdullah Medical City, Makkah, Saudi Arabia.; Jastaniah WA; King Faisal Specialist Hospital & Research Center - Jeddah, Jeddah, Saudi Arabia.; Alorabi MO; Shefaa Al Orman Hospital and Clinical Oncology Department, Faculty of Medicine - Ain Shams University, Cairo, Egypt.; Darwish AD; NCI Cairo University and Baheya Foundation for Early Detection and Treatment of Breast Cancer, Cairo, Egypt.; Rabea AM; Shefaa Al Orman Hospital and National Cancer Institute Cairo, Cairo, Egypt.; Al Olayan A; Department of Oncology, King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.; Ibnshamsah F; King Fahad Specialist Hospital, Dammam, Saudi Arabia.; Errihani H; National Institute of Oncology, Mohammed V University, Rabat, Morocco.; AlKaiyat MO; Oncology Department, King Abdulaziz Medical City, Ministry of National Guard, Riyadh, Saudi Arabia.; Hussain F; University of Texas Health Science Center, San Antonio, TX, USA.; Alkattan K; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.; Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA, USA.; Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA, USA.; Tamim H; American University of Beirut, Beirut, Lebanon.; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Publisher: Innovative Healthcare Institute Country of Publication: United States NLM ID: 101768397 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-017X (Electronic) Linking ISSN: 2590017X NLM ISO Abbreviation: J Immunother Precis Oncol Subsets: PubMed not MEDLINE

Harvey RD; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.; Miller TM; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York, USA.; Hurley PA; American Society of Clinical Oncology, Alexandria, Virginia, USA.; Thota R; Intermountain Health, Salt Lake City, Utah, USA.; Black LJ; Sanford Health, Sioux Falls, South Dakota, USA.; Bruinooge SS; American Society of Clinical Oncology, Alexandria, Virginia, USA.; Boehmer LM; Association of Community Cancer Centers, Rockville, Maryland, USA.; Fleury ME; American Cancer Society Cancer Action Network, Washington, District of Columbia, USA.; Kamboj J; Allina Health System, River Falls, Wisconsin, USA.; Rizvi MA; Hematology Oncology Associates, Medford, Oregon, USA.; Symington BE; Sweetwater Regional Cancer Center, Rock Springs, Wyoming, USA.; Tap WD; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Waterhouse DM; Oncology Hematology Care, Inc., Cincinnati, Ohio, USA.; Levit LA; American Society of Clinical Oncology, Alexandria, Virginia, USA.; Merrill JK; American Society of Clinical Oncology, Alexandria, Virginia, USA.; Prindiville SA; National Cancer Institute Coordinating Center for Clinical Trials, Bethesda, Maryland, USA.; Pollastro T; Metastatic Breast Cancer Alliance, Mercer Island, Washington, USA.; Brewer JR; US Food and Drug Administration, Rockville, Maryland, USA.; Byatt LP; New Mexico Cancer Care Alliance, Albuquerque, New Mexico, USA.; Hamroun L; ChristianaCare OPACT, Newark, Delaware, USA.; Kim ES; City of Hope, Duarte, California, USA.; Holland N; American Society of Clinical Oncology, Alexandria, Virginia, USA.; Nowakowski GS; Mayo Clinic, Rochester, Minnesota, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: PubMed not MEDLINE; MEDLINE

Lichtenstein MRL; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Levit LA; Center for Research and Analytics, American Society of Clinical Oncology, Alexandria, VA, USA.; Schenkel C; Center for Research and Analytics, American Society of Clinical Oncology, Alexandria, VA, USA.; Kirkwood K; Center for Research and Analytics, American Society of Clinical Oncology, Alexandria, VA, USA.; Fashoyin-Aje LA; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA.; Bruinooge SS; Center for Research and Analytics, American Society of Clinical Oncology, Alexandria, VA, USA.; Kelley MJ; Department of Medicine, Duke Cancer Institute and Medical Oncology, Duke University Medical Center, and Hematology-Oncology, Durham VA Medical Center, Durham, NC, USA.; Mailman JA; NorCal CarciNET Community, San Francisco, CA, USA.; Magnuson A; Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.; Mirda DP; Providence Medical Group Northern California Napa, CA, USA.; Natesan D; University of North Carolina, Chapel Hill, NC, USA.; Hershman DL; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE